Intercept Pharmaceuticals Aktie

Kaufen
Verkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Bei einem anderen Broker handeln Smartphone
Div. Rendite 0,00%

WKN A1J5U0

ISIN US45845P1084

Symbol ICPT


Intercept Pharmaceuticals Aktie Analyse

10.05.19 Intercept Pharmaceuticals Buy B. Riley FBR
14.01.19 Intercept Pharmaceuticals Buy Laidlaw
12.12.18 Intercept Pharmaceuticals Buy B. Riley FBR
19.11.18 Intercept Pharmaceuticals Outperform Oppenheimer & Co. Inc.
01.10.18 Intercept Pharmaceuticals Overweight Cantor Fitzgerald
01.11.17 Intercept Pharmaceuticals Buy Laidlaw
04.10.17 Intercept Pharmaceuticals Outperform RBC Capital Markets
26.09.17 Intercept Pharmaceuticals Outperform RBC Capital Markets
15.09.17 Intercept Pharmaceuticals Outperform RBC Capital Markets
04.08.17 Intercept Pharmaceuticals Outperform BMO Capital Markets
30.12.16 Intercept Pharmaceuticals Outperform Wedbush Morgan Securities Inc.
01.06.16 Intercept Pharmaceuticals Outperform Wedbush Morgan Securities Inc.
08.04.16 Intercept Pharmaceuticals Outperform BMO Capital Markets
24.02.16 Intercept Pharmaceuticals Outperform Wedbush Morgan Securities Inc.
18.11.15 Intercept Pharmaceuticals Outperform Oppenheimer & Co. Inc.
21.05.15 Intercept Pharmaceuticals overweight Barclays Capital
17.04.15 Intercept Pharmaceuticals Buy UBS AG
28.01.15 Intercept Pharmaceuticals Outperform Oppenheimer & Co. Inc.
04.12.14 Intercept Pharmaceuticals Outperform Robert W. Baird & Co. Incorporated
Werbung